甲基-2,6-二硫酸盐通过Keap1/Nrf2通路激活恢复了COPD中的肺功能
Zhao Li1,2,3,4, Jun Chen5, Jiadong Zhang1,2,3
1College of Emergency Trauma, Hainan Medical University, Haikou, Hainan, People's Republic of China.
Journal of inflammation research
|July 23, 2025
概括
甲基-2,6-二硫酸盐 (AH2QDS) 通过减少氧化损伤和炎症,有效治疗慢性阻塞性肺病 (COPD). 这种抗氧化疗法通过Keap1-Nrf2通路使肺功能正常化.
科学领域:
- 肺部医学 肺部医学
- 氧化压力研究研究 氧化压力研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的死亡原因,主要是由氧化损伤引起的.
- 目前对COPD的治疗策略很难有效地减轻氧化应激和恢复肺功能.
- 甲基-2,6-二硫酸盐 (AH2QDS) 具有强大的抗氧化特性,但其在COPD中的有效性仍在研究中.
研究的目的:
- 在COPD模型中研究AH2QDS的治疗潜力.
- 阐明AH2QDS作用的基本机制,重点关注Keap1-Nrf2通路.
- 为了评估AH2QDS对肺功能,氧化应激,炎症和COPD中的亡的影响.
主要方法:
- 使用脂多糖 (LPS) 和香烟烟雾/抽取物 (CS/CSE) 建立的体内和体外COPD模型.
- 评估了肺功能参数,组织病理学,氧化应激标志物,炎症性细胞因子和亡.
- 利用分子对接来预测AH2QDS与Keap1-Nrf2蛋白质的相互作用,通过免疫阻塞检测得到证实.
主要成果:
- 在COPD模型大鼠中,AH2QDS治疗显著改善了肺功能,并减轻了肺组织损伤.
- 观察到活性氧物种 (ROS),炎症性细胞因子 (TNF-α,IL-6,IL-1β,IL-33) 和亡的水平降低.
- AH2QDS上调了抗氧化酶 (SOD,CAT,GSH-PX) 和Keap1-Nrf2通路,包括Nrf2,HO-1和NQO1的表达.
结论:
- AH2QDS有效抵消氧化损伤,并减少COPD中的炎症.
- 通过AH2QDS激活Keap1-Nrf2通路是其治疗作用的关键机制.
- AH2QDS在COPD患者的肺功能正常化方面显示出显著的潜力.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Oxidation of Phenols to Quinones
3.5K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.5K
COPD: Management Using Bronchodilators and Corticosteroids
315
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
315
COPD: Pathogenesis and Clinical Features
529
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
529
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
The Electron Transport Chain
17.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.3K


